What is the permissible low diastolic blood pressure when taking Entresto (sacubitril/valsartan)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Research

Entresto can be used in patients with low diastolic blood pressure, but caution is advised when diastolic pressure falls below 60 mmHg, as evidenced by the most recent study in 2024 1.

Key Considerations

  • The use of Entresto (sacubitril/valsartan) in patients with heart failure requires careful monitoring of blood pressure, especially in those with low baseline diastolic blood pressure.
  • While there is no absolute minimum diastolic pressure cutoff for Entresto use, healthcare providers typically monitor patients closely if their diastolic pressure is consistently below 60 mmHg.
  • Entresto works by inhibiting both neprilysin and the angiotensin receptor, which can lower blood pressure as part of its therapeutic effect in heart failure.

Dosing and Monitoring

  • When starting Entresto, the recommended approach is to begin with a lower dose (24/26 mg twice daily) in patients with low baseline blood pressure and gradually titrate upward as tolerated.
  • Dose adjustments may be necessary based on individual patient response and symptoms.
  • Patients should report symptoms of hypotension such as dizziness, lightheadedness, or fainting.
  • Regular blood pressure monitoring is essential during Entresto therapy, especially during dose adjustments or when adding other medications that might further lower blood pressure.

Evidence-Based Recommendations

  • The 2024 study 1 found that patients with symptomatic hypotension were older and more frequently had cardiovascular comorbidities compared to those developing only asymptomatic hypotension.
  • The study also found that the benefits of sacubitril/valsartan were maintained (or even enhanced) in patients experiencing hypotension, as evidenced by the hazard ratio for sacubitril/valsartan vs enalapril being 0.80 (95% CI: 0.72-0.89) for no hypotension, 0.87 (95% CI: 0.70-1.08) for asymptomatic hypotension, and 0.51 (95% CI: 0.38-0.69) for symptomatic hypotension (Pinteraction = 0.01).
  • Another study in 2024 2 found that a higher left ventricular ejection fraction (LVEF) was associated with an increased risk of hypotension in patients treated with sacubitril/valsartan compared with valsartan.

Related Questions

In an 80‑plus‑year‑old male with a pacemaker who is taking apixaban, bisoprolol, Entresto (sacubitril/valsartan), and Imdur (isosorbide mononitrate) and now presents with hypotension (systolic 90‑100 mm Hg, diastolic 60‑70 mm Hg), which cardiac medications should be withdrawn or dose‑adjusted and what is the appropriate management?
In a 65-year-old male with dilated cardiomyopathy (left ventricular ejection fraction 29%) on oral torsemide, spironolactone, sacubitril/valsartan, and aspirin who presents with sudden hypotension and chest tightness (and has been started on norepinephrine infusion and BiPAP), what is the diagnosis and appropriate treatment including drug dosages?
Is antihypertensive medication required for a 20‑year‑old male taking sertraline 50 mg and alprazolam 0.25 mg who has frequent elevated blood pressure readings?
What are the next steps for a patient with uncontrolled hypertension on carvedilol (beta blocker), hydrochlorothiazide (HCTZ) (thiazide diuretic), amlodipine (calcium channel blocker), and olmesartan (angiotensin II receptor blocker) with blood pressures consistently above 170/100?
For a patient with hypertension, is starting an ACE inhibitor 2.5mg and amlodipine 5mg a suitable treatment approach?
What are the effects of aldosterone on the kidney?
Is tissue factor the same as tissue thromboplastin (tissue factor, TF)?
What is the cause of metabolic alkalosis due to excess aldosterone (a hormone)?
Is a blood pressure of 113/41 millimeters of mercury (mmHg) considered hypertensive (high blood pressure) or indicative of hypotension (low blood pressure)?
What are the medications and dosing regimens for spinal (subarachnoid) anesthesia?
What are the treatment options for severe symptoms of trapped gas, also known as dyspepsia and eructation, causing discomfort in the stomach, chest, and neck?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.